Rossari Biotech hikes prices, sees 50% jump in revenue, profit this fiscal
newsdepo.com
The board has set us a target to more than double our revenue and profit from the FY#39;20 levels by FY#39;23, both through organic as well as inorganic routes.Rossari Biotech hikes prices, sees 50% jump in revenue, profit this fiscal
The board has set us a target to more than double our revenue and profit from the FY#39;20 levels by FY#39;23, both through organic as well as inorganic routes. Read more